Semi-Annual Statement Of Income And Retained Earnings

Fuso Pharmaceutical Industries,Ltd. - Filing #7252924

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
4,131,000,000 JPY
1,964,000,000 JPY
Non-operating income
Non-operating income
235,000,000 JPY
232,000,000 JPY
Non-operating expenses
Non-operating expenses
586,000,000 JPY
328,000,000 JPY
Ordinary profit (loss)
3,780,000,000 JPY
1,868,000,000 JPY
Extraordinary income
Extraordinary income
JPY
39,000,000 JPY
Extraordinary losses
Extraordinary losses
8,751,000,000 JPY
140,000,000 JPY
Profit (loss) before income taxes
-4,970,000,000 JPY
1,767,000,000 JPY
Income taxes - current
1,029,000,000 JPY
425,000,000 JPY
Income taxes - deferred
-2,711,000,000 JPY
-35,000,000 JPY
Profit (loss)
-3,288,000,000 JPY
-3,288,000,000 JPY
-3,288,000,000 JPY
-3,288,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.